Clear Street’s SBC Medical Group SBC Stock Holding History

Clear Street’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-9,413	Closed	-$123K	–	773
2024 Q2	$123K	Buy	+9,413	New	+$126K	﹤0.01%	162
2024 Q1	–	Sell	-3,983	Closed	-$42.9K	–	855
2023 Q4	$42.9K	Buy	3,983 +1,183	+42%	+$12.7K	﹤0.01%	183
2023 Q3	$29.9K	Sell	2,800 -1,003	-26%	-$10.6K	﹤0.01%	330
2023 Q2	$39.1K	Buy	+3,803	New	+$39.3K	﹤0.01%	477
2023 Q1	–	Sell	-2,820	Closed	-$29K	–	1279
2022 Q4	$29K	Buy	+2,820	New	+$28.5K	﹤0.01%	319

Other funds holding SBC

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TCM

Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Clear Street's SBC Position: Q3 2024 in Review

Clear Street sold out of SBC Medical Group (SBC) in Q3 2024, closing a stake of 9,413 shares — an estimated $123K sold.

Clear Street first reported a position in SBC in Q4 2022 and held it in 5 quarters. The position peaked at $123K in Q2 2024. 3 funds tracked by Wall St. Rank hold SBC as of Q3 2024.

Clear Street reported no remaining SBC Medical Group position as of Q3 2024 after selling out during the quarter.
Clear Street sold 9,413 SBC Medical Group shares in Q3 2024, an estimated $123K.
Clear Street first reported a position in SBC Medical Group in Q4 2022 and held it in 5 quarters.
Clear Street's SBC Medical Group position peaked at $123K in Q2 2024.
3 funds tracked by Wall St. Rank held SBC Medical Group as of Q3 2024.

Based on Clear Street's 13F filing for Q3 2024, filed 14 Nov 2024.